Document Detail

Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features.
MedLine Citation:
PMID:  15883708     Owner:  NLM     Status:  MEDLINE    
This review focuses on CNS hemangioblastomas in von Hippel-Lindau (VHL) disease. The pathogenesis of these lesions remains unclear to date; however, biallelic inactivation of the VHL tumor suppressor gene is thought to be an important step. These benign tumors occur frequently in patients with VHL disease and produce symptoms by mass effect either by the tumor itself or an accompanying cyst or edema. Furthermore, cases of spontaneous hemorrhage have been described. Genetic testing for VHL germline mutations is recommended in all patients with hemangioblastoma and yearly screening, including MRI of the brain and spine, is recommended for all VHL disease patients. Treatment of these tumors is mainly surgical. In general, surgery is indicated in symptomatic hemangioblastomas and eventually also in asymptomatic tumors that exhibit radiographic progression. However, since most VHL disease patients harbor multiple lesions, a careful individual decision must be made in each case. The tumors can usually be completely removed by dissection in the plane between tumor and CNS tissue and coagulating and cutting of the numerous feeding vessels with low power. As long as consequent yearly surveillance is performed and lesions are adequately treated in time, the prognosis of CNS hemangioblastomas in VHL disease is good. Preoperative neurological deficit, however, will not improve after surgery in most patients. Local tumor recurrences are rare.
Sven Gläsker
Related Documents :
15883708 - Central nervous system manifestations in vhl: genetics, pathology and clinical phenotyp...
16027168 - Genetic analysis of pten and tsc2 functional interactions in the mouse reveals asymmetr...
9349498 - Frequent deletions of fhit and fra3b in barrett's metaplasia and esophageal adenocarcin...
18719378 - Functional integration of micrornas into oncogenic and tumor suppressor pathways.
19208248 - The term "carcinoid" is a misnomer: the evidence based on local invasion.
11062718 - Significance of tumor associated tissue eosinophilia and other inflammatory cell infilt...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Familial cancer     Volume:  4     ISSN:  1389-9600     ISO Abbreviation:  Fam. Cancer     Publication Date:  2005  
Date Detail:
Created Date:  2005-05-10     Completed Date:  2005-09-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100898211     Medline TA:  Fam Cancer     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  37-42     Citation Subset:  IM    
Department of Neurosurgery, Albert-Ludwigs-University, 79106 Freiburg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Central Nervous System Neoplasms / etiology*,  genetics*,  physiopathology,  surgery
Disease Progression
Hemangioblastoma / etiology*,  genetics*,  physiopathology,  surgery
von Hippel-Lindau Disease / complications*,  genetics*,  physiopathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multiple endocrine neoplasia type 2.
Next Document:  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.